Hypovolemia alone or in conjunction with other factors is a main reason for acute renal failure in critically ill patients. Various crystalloid and colloid solutions are available to correct hypovolemia. Some of them have been implicated in impairment of renal function. Infusion of large amounts of sodium chloride is associated with increased incidence of nausea, vomiting and hyperchloremic metabolic acidosis. While gelatins and HES are preferred colloids in patients with normal kidney function, there is some evidence that the latter are associated with impaired renal function in patients with pre-existing kidney disease. Any hyperoncotic colloid given in large amounts may decrease glomerular filtration, and should therefore be combined with crystalloids.
MehtaR.L., ClarkW.C., SchetzM.Techniques for assessing and achieving fluid balance in acute renal failure. Curr Opin Crit Care2002; 8: 535–43.
2.
GroeneveldA.B.J., ThijsL.G.Hypovolemic shock. In: ParrilloJ.E., BoneR.C., ed. Critical care medicine: Principles of diagnosis and management.St. Louis: Mosby, 1995; pp. 387–418.
SchadtJ.C., LudbrookJ.Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals. Am J Physiol1991; 260: H305–18.
5.
SchierhoutG., RobertsI.Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: A systematic review of randomised trials. BMJ1998; 316: 961–4.
6.
VermeulenL.C.Jr., RatkoT.A., ErstadB.L., BrecherM.E., MatuszewskiK.A.A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med1995; 155: 373–9.
7.
ChoiP.T., YipG., QuinonezL.G., CookD.J.Crystalloids vs colloids in fluid resuscitation: A systematic review. Crit Care Med1999; 27: 200–10.
8.
AstizM.E., RackowE.C.Crystalloid-colloid controversy revisited. Crit Care Med1999; 27: 34–5.
9.
KreimeierU., PeterK.Strategies of volume therapy in sepsis and systemic inflammatory response syndrome. Kidney Int1998; 53(suppl 64): S75–9.
10.
WilcoxC.S.Regulation of renal blood flow by plasma chloride. J Clin Invest1983; 71: 726–35.
11.
WilliamsE.L., HildebrandK.L., McCormickS.A., BedelM.J.The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg1999; 88: 999–1003.
12.
McFarlaneC., LeeA.A comparison of Plasmalyte 148 and 0.9% saline for intra-operative fluid replacement. Anaesthesia1994; 49: 779–81.
WilkesN.J., WoolfR., MutchM., MallettS.V., PeacheyT., StephensR., MythenM.G.The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg2001; 93: 811–6.
15.
MoranM., KapsnerC.Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med1987; 317: 150–3.
16.
BaronJ.F.Crystalloids versus colloids in the treatment of hypovolemic shock. In: VincentJ-L, ed. Yearbook of intensive care and emergency medicine.Berlin: Springer2000; pp. 443–66.
17.
MyersB.D., ChuiF., HilbermanM., MichaelsA.S.Transtubular leakage of glomerular filtrate in human acute renal failure. Am J Physiol1979; 237: F319–25.
18.
MyersB.D., CarrieB.J., YeeR.R., HilbermanM., MichaelsA.S.Pathophysiology of hemodynamically mediated acute renal failure in man. Kidney Int1980; 18: 495–504.
19.
MoranS.M., MyersB.D.Pathophysiology of protracted acute renal failure in man. J Clin Invest1985; 76: 1440–8.
20.
DiomiP., EricssonJ.L., MathesonN.A.Effects of dextran 40 on urine flow and composition during renal hypoperfusion in dogs with osmotic nephrosis. Ann Surg1970; 172: 813–24.
21.
LegendreC., ThervetE., PageB., PercheronA., NoelL.H., KreisH.Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet1993; 342: 248–9.
22.
KiefH.Morphological findings following single or multiple administration of gelatin plasma substitutes. Bibl Haematol1969; 33: 367–79.
23.
FlemingS.J., DallemagneC.R., EndreZ.H., YesbergN.E., CrossR.B.Acute lowering of plasma oncotic pressure increases filtration fraction and sodium excretion in conscious sheep. Ren Physiol Biochem1992; 15: 334–40.
24.
Hamilton-DaviesC., MythenM.G., SalmonJ.B., JacobsonD., ShuklaA., WebbA.R.Comparison of commonly used clinical indicators of hypovolaemia with gastrointestinal tonometry. Intensive Care Med1997; 23: 276–81.
25.
EdouardA.R., DegremontA.C., DuranteauJ., PussardE., BerdeauxA., SamiiK.Heterogeneous regional vascular responses to simulated transient hypovolemia in man. Intensive Care Med1994; 20: 414–20.
26.
ShippyC.R., AppelP.L., ShoemakerW.C.Reliability of clinical monitoring to assess blood volume in critically ill patients. Crit Care Med1984; 12: 107–12.
27.
BoldtJ., HeesenM., MüllerM., PapsdorfM., HempelmannG.The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg1996; 83: 254–61.
28.
BoldtJ.Human albumine on the intensive care unit: Can we live without it. In: VincentJ-L, ed. Yearbook of intensive care and emergency medicine.Berlin: Springer2000: pp. 467–75.
29.
GolubR., SorrentoJ.J.Jr., CantuR.Jr., NiermanD.M., MoideenA., SteinH.D.Efficacy of albumin supplementation in the surgical intensive care unit: A prospective, randomized study. Crit Care Med1994; 22: 613–9.
30.
Human albumin administration in critically ill patients: Systematic review of randomised controlled trials. Cochrane Injuries Group Albumin Reviewers. BMJ1998; 317: 235–40.
31.
BeyerR., HarmeningU., RittmeyerO., ZielmannS., MielckF., KazmaierS., KettlerD.Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. Br J Anaesth1997; 78: 44–50.
32.
HussainS.F., DrewP.J.Acute renal failure after infusion of gelatins. BMJ1989; 299: 1137–8.
33.
TabuchiN., de HaanJ., Gallandat HuetR.C., BoonstraP.W., van OeverenW.Gelatin impairs platelet adhesion during cardiac surgery. Thromb Haemost1995; 74: 1447–51.
KurnikB.R., SingerF., GrohW.C.Case report: Dextran-induced acute anuric renal failure. Am J Med Sci1991; 302: 28–30.
36.
KiefH., EngelbartK.Reabsorptive vacuolization of the contorted main parts of the kidney (so-called osmotic nephrosis). Frankf Z Pathol1966; 75: 53–65.
37.
MaillouxL., SwartzC.D., CapizziR., KimK.E., OnestiG., RamirezO., BrestA.N.Acute renal failure after administration of low-molecular weight dextran. N Engl J Med1967; 277: 1113–8.
38.
MessmerK.F.The use of plasma substitutes with special attention to their side effects. World J Surg1987; 11: 69–74.
39.
LaxenaireM.C., CharpentierC., FeldmanL.Anaphylactoid reactions to colloid plasma substitutes: Incidence, risk factors, mechanisms: A French multicenter prospective study. Ann Fr Anesth Reanim1994; 13: 301–10.
40.
BoldtJ., PriebeH.J.Intravascular volume replacement therapy with synthetic colloids: Is there an influence on renal function?Anesth Analg2003; 96: 376–82.
41.
CittanovaM.L., LeblancI., LegendreC., MouquetC., RiouB., CoriatP.Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet1996; 348: 1620–2.
42.
SchortgenF., LacheradeJ.C., BruneelF.Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study. Lancet2001; 357: 911–6.
43.
BoldtJ., MullerM., MentgesD., PapsdorfM., HempelmannG.Volume therapy in the critically ill: Is there a difference?Intensive Care Med1998; 24: 28–36.
44.
LondonM.J., HoS.J., TriedmanJ.K.A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg1989; 97: 785–97.
45.
StockwellM.A., ScottA., DayA., SoniN.Colloid solutions in the critically ill: A randomised comparison of albumin and polygeline 2 serum albumin concentration and incidences of pulmonary oedema and acute renal failure. Anaesthesia1992; 47: 7–9.
46.
GinesA., Fernandez-EsparrachG., MonescilloA.Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology1996; 111: 1002–10.
47.
VogtN.H., BothnerU., LerchG.Large-dose administration of 6% hydroxyethyl starch 200/0.5 for total hip arthroplasty: Plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Anesth Analg1996; 83: 262–8.
48.
KumleB., BoldtJ., PiperS.N.The influence of different intravascular volume replacement regimens on renal function in the elderly. Anesth Analg1999; 89: 1124–30.
49.
AllisonK.P., GoslingP., JonesS.Randomized trial of hydroxyethyl starch versus gelatine for trauma resuscitation. J Trauma1999; 47: 1114–21.
50.
DemanA., PeetersP., SennesaelJ.Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: A retrospective, multicenter analysis. Nephrol Dial Transplant1999; 14: 1517–20.
51.
BoldtJ., LehmannA., RömpertR.Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass. J Cardiothorac Vasc Anesth2000; 14: 264–8.
52.
DehneM.G., MühlingJ., SablotzkiA.Hydroxyethylstarch (HES) does not directly affect renal function in patients with no prior renal impairment. J Clin Anesth2001; 13: 103–11.
53.
RagallerM.J., TheilenH., KochT.Volume replacement in critically ill patients with acute renal failure. J Am Soc Nephrol2001; 12(suppl): S33–9.
